Harrow, Inc.

HROW Healthcare Drug Manufacturers Specialty & Generic

Harrow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $272.3 million, up 36.4% from fiscal 2024. In the quarter to June 2026, revenue grew 10.9%, EPS fell 428.6%, free cash flow fell 838.8% and total debt rose 659.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

27.28 1.47 −5.11%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
134×
Dividend yield
—
F-score
6/9
Altman Z
3.84
Beneish M
−3.04
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
211.75 189.65 139.48 118.26 60.66 40.98 36.05 32.84 8.81 14.75
Total non-current assets
187.73 199.32 172.68 39.12 37.67 16.49 23.04 16.61 15.11 12.49
Total Assets
399.48 388.97 312.16 157.38 98.33 57.47 59.09 49.45 23.92 27.25
Total current liabilities
96.30 91.34 49.34 18.63 9.72 10.80 12.28 11.90 5.77 9.91
Total non-current liabilities
251.09 228.33 192.41 111.51 77.68 19.85 19.38 12.80 15.53 10.91
Total liabilities
347.39 319.67 241.75 130.14 87.40 30.65 31.67 24.70 21.30 20.82
Common Equity (Total)
52.09 69.30 70.41 27.24 10.93 26.83 27.42 24.75 2.62 6.43
Shareholders Equity (Total)
52.09 69.30 70.41 27.24 10.93 26.83 27.42 24.75 2.62 6.43
Total Debt
243.18 219.54 185.89 104.17 71.66 16.29 14.65 15.25 15.33 13.69

Show all line items

In millions of $ except per-share values · columns are period end dates